The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yajima, T.
Right arrow Articles by Yoshikai, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yajima, T.
Right arrow Articles by Yoshikai, Y.
The Journal of Immunology, 2002, 168: 1198-1203.
Copyright © 2002 by The American Association of Immunologists

Overexpression of IL-15 In Vivo Increases Antigen-Driven Memory CD8+ T Cells Following a Microbe Exposure1

Toshiki Yajima*,{dagger}, Hitoshi Nishimura*, Ryotaro Ishimitsu*, Taketo Watase*, Dirk H. Busch{ddagger}, Eric G. Pamer§, Hiroyuki Kuwano{dagger} and Yasunobu Yoshikai2,*

* Laboratory of Host Defense, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Nagoya, Japan; {dagger} First Department of Surgery, Gunma University School of Medicine, Maebashi, Japan; {ddagger} Sections of Infectious Diseases and Immunology, Yale University School of Medicine, New Haven, CT 06520; § Infectious Disease Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Immunology Program, Sloan-Kettering Institue, New York, NY 10021


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
To elucidate potential roles of IL-15 in the maintenance of memory CD8+ T cells, we followed the fate of Ag-specific CD8+ T cells directly visualized with MHC class I tetramers coupled with listeriolysin O (LLO)91–99 in IL-15 transgenic (Tg) mice after Listeria monocytogenes infection. The numbers of LLO91–99-positive memory CD8+ T cells were significantly higher at 3 and 6 wk after infection than those in non-Tg mice. The LLO91–99-positive CD8+ T cells produced IFN-{gamma} in response to LLO91–99, and an adoptive transfer of CD8+ T cells from IL-15 Tg mice infected with L. monocytogenes conferred a higher level of resistance against L. monocytogenes in normal mice. The CD44+CD8+ T cells from infected IL-15 Tg mice expressed the higher level of Bcl-2. Transferred CD44+CD8+ T cells divided more vigorously in naive IL-15 Tg mice than in non-Tg mice. These results suggest that IL-15 plays an important role in long-term maintenance of Ag-specific memory CD8+ T cells following microbial exposure via promotion of cell survival and homeostatic proliferation.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Antigen-specific memory T cell responses are of vital importance in establishment of protective immunity against microbial infection. Upon encounter with a pathogenic microbe, Ag-specific T cells proliferate and differentiate into activated effector T cells. Most of the activated T cells die by apoptosis (1), but the few that survive become memory cells and persist for a long period of time, sometimes throughout the life of an animal (2, 3, 4). It has recently been reported that naive T cells directly acquire a memory phenotype in the absence of overt antigenic stimulation (5, 6, 7, 8, 9). The prolonged survival of this type of memory CD8+ T cell requires low-level TCR signaling from contact with a self-MHC/peptide ligand but neither IL-2 nor costimulation via CD28 (6, 7). In contrast, Ag-driven memory CD8+ T cells can persist even in the absence of MHC class I (10, 11). Recent studies have suggested that cytokines such as IL-15 seemed to be involved in the proliferation and survival of the Ag-driven memory CD8+ T cells, especially central memory phenotype in the CD8+ T cells (5, 12, 13, 14). However, direct evidence for the involvement of IL-15 in the maintenance of Ag-driven memory CD8+ T cells has not yet been obtained.

IL-15 uses {beta}- and {gamma}-chains of IL-2R for signal transduction and thus shares many properties of IL-2 despite having no sequence homology with it (15, 16, 17, 18). Similar to IL-2, IL-15 promotes activation, proliferation, and cytokine release of various subsets of T, NK, and B cells (19, 20, 21). However, in contrast to IL-2, which accelerates activation-induced cell death in CD8+ T cells, IL-15 maintains the homeostasis of memory phenotype CD8+ T cells (22, 23). We have previously constructed transgenic (Tg)3 mice expressing IL-15 cDNA encoding a secretable isoform of the IL-15 precursor protein under the control of an MHC class I promoter, and we found that the IL-15 Tg mice, producing IL-15 constitutively, had markedly increased numbers of memory-type (CD44highLy6C+) CD8+ T cells in the periphery lymphoid tissue (22). IL-15 Tg mice showed resistance against infection with Salmonella choleraesuis, Listeria monocytogenes, or Mycobacterium bovis accompanied by marked increases in memory CD8+ T cells (22, 24, 25). We have also reported that IL-15 Tg mice showed increased CD8+ Tc1 cell responses producing IFN-{gamma} following multiple immunization with OVA/CFA (26). Thus, our IL-15 Tg mice may be useful for determining molecular mechanisms whereby IL-15 play a role in generation and/or maintenance of Ag-driven memory CD8+ T cells.

To this end, we followed the fate of Ag-specific CD8+ T cells directly visualized with MHC class I tetramers coupled with listeriolysin O (LLO)91–99 in IL-15 Tg mice after L. monocytogenes infection. We found that the number of LLO91–99-specific CD8+ T cells had increased significantly at 3 and 6 wk after infection in IL-15 Tg mice. Both cell survival and homeostatic proliferation of Ag-specific memory CD8+ T cells are suggested to be involved in persistence of Ag-specific memory CD8+ T cells in IL-15 Tg mice.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice

IL-15 Tg mice (C57BL/6 background, H-2b, Ly5.2), which were constructed using originally described IL-15 cDNA, have been described previously (22). IL-15 Tg mice with C57BL/6 background were backcrossed onto the BALB/c (H-2d) background more than eight times. Age- and sex-matched BALB/c (H-2d) mice were obtained from Japan SLC (Hamamatsu, Japan). (IL-15 Tg x BALB/c)F1 mice, (C57BL/6 x BALB/c)F1 mice, and B6-Ly5.1 mice (H-2b, Ly5.1) were bred in our laboratory. Mice were maintained under specific pathogen-free conditions and were offered food and water ad libitum. All mice were used at 6–8 wk of age.

Microorganism

L. monocytogenes, strain EGD, was used in all experiments. Bacterial virulence was maintained by serial passages in BALB/c mice. Fresh isolates were obtained from infected spleens grown in tryptic soy broth (Nissui Pharmaceutical, Tokyo, Japan), washed repeatedly, resuspended in PBS, and stored at -70°C in small aliquots. Mice were inoculated i.p. with various doses of viable L. monocytogenes in 0.2 ml of PBS on day 0. The spleen and liver were removed and separately placed in homogenizers containing 2 ml of HBSS. These samples were spread on trypto-soya agar plates, and colonies were counted after incubation for 24 h at 37°C.

Abs and reagents

FITC-conjugated anti-CD44 (IM7), anti-CD69 (H1.2F3), anti-Ly6C (AL-21), and anti-IFN-{gamma} (XMG1.2); PE-conjugated anti-CD8{alpha} (53-6.7), anti-CD44 (IM7), anti-CD62L (MEL-14), and anti-CD25 (7D4); CyChrome-conjugated anti-CD8{alpha} (53-6.7), and anti-CD4 (RM4-5); and biotin-conjugated anti-Ly5.1 (A20) were purchased from BD PharMingen (San Diego, CA). CyChrome and allophycocyanin-conjugated streptavidin were also obtained from BD PharMingen. CFSE was purchased from Molecular Probes (Eugene, OR).

Generation of H2-Kd tetramers

MHC-peptide tetramers for staining of epitope-specific cells were generated as recently described (27, 28). Briefly, purified H chain and {beta}2-microgobulin were dissolved in 8 M urea and diluted in a refolding buffer containing high concentrations of synthetic peptide LLO91–99 (29) or the Janus kinase (JAK)1 self-peptide (30) to generate monomeric, soluble H2-Kd-peptide complexes. Biotinylation and tetramerization of the heterodimer were performed as described by Altman et al. (27). The monomeric complexes were tetramerized by the addition of PE-labeled streptavidin (BD PharMingen) at a molar ratio of 4:1.

Flow cytometry analysis

The cells were incubated with saturating amounts of FITC-, PE-, CyChrome-, and biotin-conjugated mAbs for 30 min at 4°C. To detect biotin-conjugated mAbs, cells were stained with CyChrome or allophycocyanin-conjugated streptavidin. For staining of epitope-specific CD8+ T cells using tetrameric H2-Kd-peptide complexes, cells were incubated at 4°C for 20 min in unconjugated streptavidin (0.5 mg/ml; Sigma-Aldrich, St. Louis, MO) and Fc-block (2.4G2), followed by triple staining with FITC-CD44, CyChrome-CD8{alpha}, and PE-conjugated tetrameric H2-Kd/peptide complex (0.2–0.5 mg/ml) for 30 min at 4°C. The cells were analyzed using an FACSCalibur flow cytometer (BD Biosciences, San Jose, CA).

Analysis of intracellular cytokine synthesis

The spleen cells from infected mice were harvested, washed, and suspended at 106 cells/ml in complete culture medium, and then were incubated for 4 h at 37°C in the presence of 10 µg/ml brefeldin A (Sigma-Aldrich), 5 µg/ml LLO91–99, or JAK1 peptide. These cells were harvested, washed, and incubated for 30 min at 4°C with PE-conjugated anti-CD44 mAb and CyChrome-conjugated CD8 mAb. After surface staining, cells were subjected to intracellular cytokine staining using the Fast Immune Cytokine System according to the manufacturer’s instructions (BD Biosciences). The cells were washed and fixed in 1000 µl of FACS lysing solution (BD Biosciences) for 10 min at room temperature and were then washed again, resuspended in 500 µl of FACS permeabilizing solution (BD Biosciences), and incubated for 10 min at room temperature. After washing, the cells were stained with FITC-conjugated IFN-{gamma} mAb or FITC-conjugated isotype control rat IgG (BD PharMingen) for 30 min at room temperature, and the fluorescence of the cells was analyzed using a flow cytometer.

Before staining for intracellular Bcl-2, cells were stained for cell surface Ags as describe above. After washing, cells were fixed and permeabilized with above solution. Cells were stained with either FITC-conjugated hamster anti-mouse Bcl-2 mAb (3F11) or its isotype FITC-conjugated control Ab to hamster (BD PharMingen).

Adoptive transfer assays

Nylon wool-enriched spleen T cells were incubated with appropriate dilutions of FITC-conjugated anti-I-Ad, IgM, and biotinylated anti-DX-5, -CD11c, and -{gamma}{delta}TCR mAbs, and were washed twice in HBSS. The cells were then incubated with anti-FITC microbeads, streptavidin microbeads, and anti-CD4 mAb microbeads for 15 min at 4°C. CD8+ T cells were enriched to >90% by negative selection using LD+ depletion columns (Miltenyi Biotec, Bergisch Gladbach,Germany). Enriched CD8+ T cells (1 x 107 cells) were adoptively transferred into recipient mice via tail vein inoculation. At 12 h after adoptive transfer of these cells, mice were i.p. challenged with a lethal dose of L. monocytogenes (1 x 106 CFU) and 3 days later the number of bacteria in the peritoneal cavity, spleen, and liver were counted. In an another experiment, purified CD8+ T cells from Ly5.1-B6 mice infected with L. monocytogenes 7 days previously were suspended at a concentration of 1–5 x 107/ml in PBS and then labeled with CFSE at a concentration of 5 mM for 10 min. CFSE-labeled CD8+ T cells were inoculated i.v. into naive (IL-15 Tg x BALB/c)F1 mice or naive (C57BL/6 x BALB/c)F1 mice. After 6 wk, transferred Ly5.1+ T cells were analyzed using a flow cytometer.

RT-PCR

LLO91–99-specific CD44+CD8+ T cells were sorted from IL-15 Tg or non-Tg mice on day 7 or 21 after L. monocytogenes infection using FACSVantage (BD Biosciences). The first-strand cDNA synthesized from the mRNA was amplified using 10 pmol of each primer specific for murine {beta}-actin, CCR7, CXCR3, Bcl-2, Bcl-XL, or caspase-8/Fas-associated death domain protein-like IL-1{beta}-converting enzyme inhibitory protein (FLIP). The specific primers were as follows: {beta}-actin sense, 5'-GGAATCCTGTGGCATCCATGAAAC-3'; antisense, 5'-TAAAACGCAGCTCAGTAACAGTCCG-3'; CCR7 sense, 5'-GAGATGCTCACTGGTCAGTG-3'; antisense, 5'-CTACGGGGAGAAGGTTGTGG-3'; CXCR3 sense, 5'-CAACATCAACTTCTATGCAG-3'; antisense, 5'-AGGATATGGGCATAGCAGTA-3'; Bcl-2 sense, 5'-TGGCCTTCTTTGAGTTCGGT-3'; antisense, 5'-AGCCTCCGTTATCCTGGATC-3'; Bcl-XL sense, 5'-CCGGAGAGCGTTCAGTGATC-3'; antisense, 5'-TCAGGAACCAGCGGTTGAAG-3'; and FLIP sense, 5'-GTCACATGACATAACCCAGATTGT-3'; and antisense, 5'-GTACAGACTGCTCTCCCAAGCACT-3'. The PCR products were separated on 1% agarose gels, transferred to a GeneScreen Plus filter (NEN, Boston, MA), and hybridized with 32P-labeled oligo probes. The oligonucleotide probes were as follows: {beta}-actin, 5'-TTCTGCATCCTGTCAGCAAT-3'; CCR7, 5'-CGCCGATGAAGGCATACAAG-3'; CXCR3, 5'-CTCACCTGCATAGTTGTATG-3'; Bcl-2, 5'-CCGGTTCAGGTACTCAGTCA-3'; Bcl-XL, 5'-CTGCATCTCCTTGTCTACGC-3'; and FLIP, 5'-CTAAGGAATGTAAGTAGGGA-3'.

Statistical analysis

Data were analyzed by Student’s t test, and a Bonferroni correction was applied for multiple comparison. The value of p < 0.05 was considered statistically significant.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Kinetics of LLO91–99-specific CD8+ T cells in IL-15 Tg mice after L. monocytogenes infection

To directly follow the fate of the L. monocytogenes epitope-specific CD8+ T cells in IL-15 Tg mice after an i. p. inoculation with 1 x 105 CFU of L. monocytogenes, tetrameric MHC molecule folding with the LLO91–99 peptide, the immunodominant epitope recognized by H2-Kd-restricted CD8+ T cells (29), was used for staining epitope-specific CD8+ T cells. Consistent with our previous finding (24), we found that the bacterial number increased to a maximal level on day 3 in the spleen and liver and thereafter cleared completely by day 10 after inoculation in both non-Tg mice and IL-15 Tg mice and that the bacteria were more rapidly eliminated in IL-15 Tg mice than in non-Tg mice (data not shown). As shown in Fig. 1Go, a significant number of CD8+ T cells expressing a high level of CD44 in non-Tg mice infected with L. monocytogenes 7 days previously were stained with H2-Kd/LLO91–99 tetramers, whereas only a few CD8+ T cells in IL-15 Tg mice were stained with H2-Kd/LLO91–99 tetramers on day 7 after infection. The absolute numbers of H2-Kd/LLO91–99 peptide-positive CD8+ T cells in the splenocytes were 2.8 ± 0.4 x 105 cells in non-Tg mice and 2.3 ± 0.9 x 105 cells in IL-15 Tg mice (Fig. 2Go). Thus, the number of LLO91–99-specific T cells in the spleen of IL-15 Tg mice was similar to that in the spleen of non-Tg mice at the early stage after infection because memory CD44+CD8+ T cells other than those specific for LLO91–99 were markedly increased in IL-15 Tg mice at this stage.



View larger version (47K):
[in this window]
[in a new window]
 
FIGURE 1. LLO91–99-specific CD8+ T cells in the spleen of IL-15 Tg mice after infection with L. monocytogenes. For staining of epitope-specific CD8+ T cells using tetrameric H2-Kd-peptide complexes, spleen cells from IL-15 or non-Tg mice infected with 1 x 105 L. monocytogenes were incubated at 4°C for 20 min in unconjugated streptavidin (0.5 mg/ml) and Fc-block (2.4G2), followed by triple staining with FITC-CD44, CyChrome-CD8{alpha}, and PE-conjugated tetrameric H2-Kd/LLO91–99 for 30 min at 4°C. The cells were analyzed using a FACSCalibur flow cytometer, and then the analysis gate was set on CD8+ T cells. Each number indicates the percentage of H2-Kd/LLO91–99-positive cells in CD8+ T cells. Data of a representative are shown from three separate experiments.

 


View larger version (23K):
[in this window]
[in a new window]
 
FIGURE 2. Kinetics of absolute number of LLO91–99-specific CD8+ T cells in IL-15 Tg mice following L. monocytogenes infection. The absolute number of LLO91–99-specific CD8+ T cells were calculated by multiplying total spleen cells by the percentage of LLO91–99-specific CD8+ T cells in spleen. Data of a representative are shown from three separate experiments and are expressed as means ± SD of five mice of each group from representative experiment. *, p < 0.05, significantly different from the value for non-Tg mice.

 
In contrast, the number of LLO91–99-specific CD8+ T cells was significantly higher on day 21 after infection than those in non-Tg mice (Figs. 1Go and 2Go; p < 0.05). Although the numbers declined by day 40 after infection in both non-Tg mice and IL-15 Tg mice, it remained at high in IL-15 Tg mice. Most of the LLO91–99-specific CD8+ T cells on day 21 or 40 after L. monocytogenes infection expressed CD122 and Ly6C but not activation markers such as CD25 and CD62L, indicating that most are of memory phenotype (data not shown). These results suggest that overexpression of IL-15 in vivo does not augment the generation of CD8+ effector T cells recognizing L. monocytogenes-specific epitope, but increases the number of Ag-driven memory CD8+ T cells after L. monocytogenes infection.

Listeria-specific memory CD8+ T cells in IL-15 Tg mice function to protect against L. monocytogenes infection

Besides Th1 response, Tc1 response also plays a critical role in protective immunity against L. monocytogenes infection (31). To determine whether the memory CD8+ T cells in IL-15 Tg mice belong to the Tc1 cell population, we used cytokine FACS analysis for expression of CD8, CD44, and intracellular IFN-{gamma}. As shown in Fig. 3Go, a significant fraction of CD44+CD8+ T cells from both groups of mice infected with L. monocytogenes 21 days previously produced IFN-{gamma} in response to LLO91–99, and the level of CD8+ Tc1 cells producing IFN-{gamma} was significantly higher in IL-15 Tg mice than in non-Tg mice at this stage. It is notable that the relative number of intracellular IFN-{gamma}-positive CD8+ T cells responding to LLO91–99 in vitro was consistent with that of CD8+ T cells directly stained with H2-Kd/LLO91–99 tetramers in non-Tg or IL-15 Tg mice, respectively (Figs. 1Go and 3Go).



View larger version (39K):
[in this window]
[in a new window]
 
FIGURE 3. Intracellular cytokine staining of LLO91–99-specific CD8+ T cells in IL-15 Tg mice infected with L. monocytogenes. The spleen cells from IL-15 Tg or non-Tg mice infected with 1 x 105 L. monocytogenes were harvested, washed, and suspended at 106 cells/ml in a complete culture medium and were then incubated for 5 h at 37°C in the presence of 10 µg/ml brefeldin A and 5 µg/ml LLO91–99 or JAK1 peptide. These cells were harvested, washed, and incubated for 30 min at 4°C with PE-conjugated anti-CD44 mAb, biotin-conjugated CD8 mAb, and then CyChrome-conjugated streptavidin. The cells were stained with FITC-conjugated IFN-{gamma} mAb for 30 min at room temperature, and the fluorescence of the cells was analyzed using a flow cytometer. The analysis gate was set on CD8+ T cells. Each number indicates the percentage of intracellular IFN-{gamma}-positive cells in CD8+ T cells. Data of a representative are shown from three separate experiments.

 
To elucidate the protective role of CD8+ T cells in IL-15 Tg mice, adoptive transfer experiments were conducted in normal mice using splenic CD8+ T cells from IL-15 Tg mice or non-Tg mice infected with L. monocytogenes 21 days previously. The CD8+ T cells from infected IL-15 Tg mice conferred a higher level of protection on normal mice against a lethal challenge with L. monocytogenes compared with those from the infected non-Tg mice (p < 0.01, Fig. 4Go). These results suggest that the Ag-specific CD8+ Tc1 cells that increase in IL-15 Tg mice following L. monocytogenes exposure can serve to protect against a challenge with L. monocytogenes.



View larger version (43K):
[in this window]
[in a new window]
 
FIGURE 4. Protection against a challenge with a lethal dose of L. monocytogenes in mice in which CD8+ T cells from L. monocytogenes-infected IL-15 Tg mice had been transferred. CD8+ T cells (1 x 107) from non-Tg or IL-15 Tg mice infected with 1 x 105 L. monocytogenes 21 days previously were adoptively transferred to recipient mice via the tail vein. At 12 h after the transfer, mice were challenged with a lethal dose of L. monocytogenes (1 x 106 CFU), and 3 days later, the number of bacteria in the spleen and liver were counted. Each column and vertical bar represent means ± SD of five mice in each group. *, p < 0.05, significant different between the values for non-TgCD8->BALB/c and these for immune non-Tg CD8->BALB/c. **, p < 0.01, significant different between the values for Tg CD8->BALB/c and those for immune Tg CD8->BALB/c or the values for immune non-Tg CD8->BALB/c and those for immune Tg CD8->BALB/c.

 
Expression of antiapoptotic proteins in Ag-driven memory CD8+ T cells in IL-15 Tg mice

Antiapoptotic molecules play a critical role in regulating cell survival and apoptosis of memory T cells (32). We next sorted LLO91–99-specific CD44+CD8+ T cells from non-Tg and IL-15 Tg mice on day 7 or 21 after infection and compared the gene expressions of CCR7, CXCR3, and antiapoptotic molecules such as Bcl-2, Bcl-XL, or FLIP. CCR7, which is expressed specifically in central memory T cells (33), was not expressed in LLO91–99-specific CD44+CD8+ T cells on day 7 after L. monocytogenes infection, but its expression was up-regulated in those cells on day 21 after L. monocytogenes infection (Fig. 5Go). These results are consistent with surface markers for effector and memory on LLO91–99-specific CD44+CD8+ T cells on day 7 or 21, respectively. CXCR3, which is expressed by Th1/Tc1 cells (34), was expressed by both LLO91–99-specific CD44+CD8+ T cells on days 7 and 21, a finding that is also consistent with CD44+CD8+ Tc1 cells capable of IFN-{gamma} production upon LLO91–99 stimulation. Notably, LLO91–99-specific CD44+CD8+ T cells in IL-15 Tg mice on day 7 after infection showed a higher level of Bcl-2 gene expression than those in non-Tg mice did. There were no remarkable differences in gene expression of Bcl-XL and that of FLIP, an inhibitor of the Fas/Fas ligand signaling pathway (35).



View larger version (33K):
[in this window]
[in a new window]
 
FIGURE 5. Gene expression of chemokine receptors and antiapoptotic proteins in LLO91–99-specific T cells from IL-15 Tg mice. mRNA was extracted from LLO91–99-specific CD44+CD8+ T cells isolated from IL-15 Tg or non-Tg mice on day 7 or 21 after L. monocytogenes infection. The synthesized first-strand cDNA was amplified by means of the PCR using 10 pmol of each primer specific for murine {beta}-actin, CCR7, CXCR3, Bcl-2, Bcl-XL, or FLIP with 2.5 U of rTaq. The PCR products were separated on 1% agarose gels, transferred to a GeneScreen plus filter (NEN), and then hybridized with 32P-labeled oligo probes. Data of a representative are shown from three separate experiments.

 
To confirm the expression of Bcl-2 at protein level, we stained Bcl-2 in LLO91–99-specific CD8+ T cells after L. monocytogenes infection. As shown in Fig. 6Go, expression of Bcl-2 in the LLO91–99 +CD8+ T cells of IL-15 Tg mice was higher on days 7 and 9 after infection compared with that of non-Tg mice. These results suggest that increased Bcl-2 expression plays a role in increase in number of LLO91–99-specific memory CD8+ T cells in vivo in IL-15 Tg mice following L. monocytogenes infection.



View larger version (23K):
[in this window]
[in a new window]
 
FIGURE 6. Bcl-2 expression on LLO91–99-specific CD8+ T cells in IL-15 Tg mice following L. monocytogenes infection. Spleen cells from non-Tg or IL-15 Tg mice on days 7, 9, 14, and 35 postinfection were stained with anti-CD8{alpha} mAb and tetrameric H2-Kd/peptide complex. The cells were stained with either FITC-conjugated hamster anti-mouse Bcl-2 or its isotype control Ab to hamster. The Bcl-2 levels in the gated populations are shown as a single histogram and each number indicates the mean fluorescence intensity. Staining with isotype control Ab was overlaid on each histogram as a dotted line. Data of a representative are shown from three separate experiments.

 
Cell division of memory CD8+ T cells in IL-15 Tg mice

The number of memory T cells is maintained by a balance among cell survival, apoptosis, and proliferation (1, 2, 3, 4). To elucidate whether cell division is involved in increases in Ag-driven memory CD8+ T cells in IL-15 Tg mice, we performed a transfer experiment with CFSE-labeled CD8+ T cells from the spleen of non-Tg mice infected with L. monocytogenes 7 days previously into naive non-Tg or IL-15 Tg mice, and we analyzed cell division in vivo 6 wk later. As shown in Fig. 7Go and Table IGo, more CD44+CD8+ T cells entered the cell cycle in IL-15 Tg mice than in non-Tg mice 6 wk after injection. These results suggest that memory CD8+ T cells persist by cell division in IL-15 Tg mice.



View larger version (28K):
[in this window]
[in a new window]
 
FIGURE 7. Cell division of memory CD8+ T cells in IL-15 Tg mice. CD8+ T cells were sorted from spleen cells of Ly5.1+ mice infected with L. monocytogenes 7 days previously using magnetic cell sorter. The CD8+ T cells were labeled with CFSE, and then 1 x 107 of the CFSE-labeled cells was adoptively transferred to naive IL-15 Tg mice or non-Tg mice. Six weeks later, spleen cells were examined for expression of CD44, CD8, and CFSE using a flow cytometer. The analysis gate was set on Ly5.1+CD8+ T cells. The percentage of cells at each division number is shown in the table. Data of a representative are shown from three separate experiments.

 

View this table:
[in this window]
[in a new window]
 
Table I. Cell division of memory CD8+ T cells

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Naive CD8+ T cells in the periphery proliferate and differentiate into effector cells upon TCR engagement with microbial peptide-MHC class I complex when microbes invade the body (31). After the battle against microbes has been won, most of the CD8+ effector T cells die by apoptosis due to activation-induced death and/or withdrawal of growth factors (1). A few cells that escape apoptosis differentiate linearly into memory-type CD8+ T cells, although the differentiation of effector and memory cells along separate lineages is not completely precluded (2, 3, 4). It is now widely accepted that Ag-driven memory CD8+ T cells are maintained independently of MHC class I (10, 11). Therefore, the survival and proliferation are driven by Ag-independent factors such as cytokines. In this study, we show evidence of an increase in the number of Ag-driven memory CD8+ T cells following a microbial infection in IL-15 Tg mice, which constitutively produce IL-15 protein in the serum (22). IL-15 may play an important role in the long-term maintenance of Ag-driven memory CD8+ T cell in vivo.

A key issue is the molecular mechanisms whereby IL-15 regulates the size of Ag-driven memory CD8+ T cells in the periphery following a microbial infection. It can be speculated that overexpression of IL-15 in vivo may enhance the generation of effector CD8+ T cells after L. monocytogenes infection, resulting in an increase in the number of memory CD8+ T cells. However, the results of our previous (24) and present studies revealed that the absolute number of LLO91–99-specific effector CD8+ T cells in IL-15 Tg mice was similar or rather smaller than that in non-Tg mice on day 7 after infection, excluding the above-mentioned possibility. The LLO91–99-specific CD8+ T cells from IL-15 Tg mice infected with L. monocytogenes 7 days previously expressed CD69 but not CCR7 mRNA, indicating that these cells are effector cells. The CD8+ effector T cells expressed a higher level of Bcl-2 genes than did those in non-Tg mice. Bcl-2 expression is induced via signaling from the common cytokine receptor {gamma}-chain (36), which is used by IL-15 (37) and prevents apoptosis by both activation-induced cell death and withdrawal of growth factors (1). In fact, annexin V expression in CD44+CD8+ T cells of IL-15 Tg mice was significantly lower on day 7 after L. monocytogenes infection than that seen in non-Tg mice (data not shown). Therefore, it is likely that overexpression of IL-15 protects the effector CD8+ T cells from apoptosis by activation-induced cell death and/or withdrawal of growth factors, resulting in an increased number of memory CD8+ T cells. We have recently reported that IL-15 Tg mice showed augmented Tc1 responses against bacillus Calmette-Guérin infection (25) and against multiple immunization with OVA in CFA (26). Augmented Tc1 responses in these reports may be explained by increases in the memory CD8+ T cells following OVA or bacillus Calmette-Guérin immunization.

Cell division is thought to be required for the long-term maintenance of Ag-driven memory CD8+ T cells in vivo (38, 39). The results of our transfer experiments suggest that the transferred CD44+CD8+ T cells divided more at 6 wk in naive IL-15 Tg mice than in naive non-Tg mice. These results suggest that memory CD8+ T cells have a higher rate of homeostatic proliferation in IL-15 Tg mice than in non-Tg mice. IL-15 may play a role in the long-term survival of memory T cells in vivo by cell division of memory CD8+ T cells in addition to protection from activation-induced apoptosis. Recent studies have provided several lines of evidence for homeostatic proliferation of naive CD8+ T cells (5, 6, 7, 8, 9). Naive CD8+ T cells can acquire characteristics of memory T cells in the absence of stimulation with a specific Ag, but by stimulation with self-MHC class I/peptide ligand (6, 7). Therefore, memory CD8+ T cells include not only true Ag-experienced cells but also memory cells derived from naive cells via homeostatic proliferation. Additional experiments are needed to elucidate the roles of IL-15 in the homeostasis of memory CD8+ T cells directly derived from naive CD8+ T cells.

IL-15 mRNA is constitutively expressed by various cells and tissues such as placenta, skeletal muscle, kidney, epithelial cells, synovial cells, and macrophages (21, 40). IL-15 expression is regulated not only at the transcriptional level but also at levels of translation and intracellular trafficking (41, 42, 43, 44, 45, 46). Hence, IL-15 protein was found to be produced only by a limited number of cells such as LPS-stimulated macrophages and bacteria-stimulated epithelial cells, but not by other cells including T cells (41, 47). Masopust et al. (48) have recently reported that Ag-specific memory T cells are maintained preferentially in nonlymphoid tissues such as lamina propria of intestine for the long term. Because IL-15 is thought to be produced abundantly in intestinal epithelium, IL-15 may play a critical role in the long-term maintenance of Ag-driven memory CD8+ T cell in the nonlymphoid tissues.

In conclusion, overexpression of IL-15 in vivo shed light on the role of IL-15 in long-term maintenance of memory CD8+ T cells in vivo. IL-15 may promote linear differentiation of effector CD8+ T cells into memory CD8+ T cells through protection from activation-induced cell death by apoptosis and may maintain memory CD8+ T cells through induction of cell division. These findings suggest that IL-15 may be useful as an immune adjuvant given with vaccination to enhance its biologic efficacy.


    Acknowledgments
 
We thank Dr. K. Kishihara for providing B6-Ly5.1 mice and K. Itano and A. Nishikawa for their excellent technical assistance.


    Footnotes
 
1 This work was supported in part by grants from the Japanese Ministry of Education, Science and Culture (JSPS-RFTF9 7L00703, to Y.Y.), by the Yamada Science Foundation, by the Yasuda Medical Research Foundation, and by the Yakult Bioscience Foundation. Back

2 Address correspondence and reprint requests to Dr. Yasunobu Yoshikai, Laboratory of Host Defense, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Nagoya 466-8550, Japan. E-mail address; yyoshika{at}med.nagoya-u.ac.jp Back

3 Abbreviations used in this paper: Tg, transgenic; LLO, listeriolysin O; FLIP, caspase-8/Fas-associated death domain protein-like IL-1{beta}-converting enzyme inhibitory protein; JAK, Janus kinase. Back

Received for publication September 26, 2001. Accepted for publication November 29, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Lenard, M., F. Ka-Ming Chang, F. Hornung, H. McFarland, R. Siegel, J. Wang, L. Zheng. 1999. Mature T lymphocytes apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17:221.[Medline]
  2. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. D. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177.[Medline]
  3. Opferman, J. T., B. T. Ober, P. G. Ashton-Rickardt. 1999. Linear differentiation of cytotoxic effectors into memory T lymphocytes. Science 283:1745.[Abstract/Free Full Text]
  4. Jacob, J., D. Baltimore. 1999. Modeling T-cell memory by genetic marking of memory T cells in vivo. Nature 399:593.[Medline]
  5. Ku, C. C., M. Murakami, A. Sakamoto, J. Kappler, P. Marrack. 2000. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 288:675.[Abstract/Free Full Text]
  6. Goldrath, A. W., L. Y. Bogatzki, M. J. Bevan. 2000. Naïve T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J. Exp. Med. 192:557.[Abstract/Free Full Text]
  7. Cho, B. K., V. P. Rao, Q. Ge, H. N. Eisen, J. Chen. 2000. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J. Exp. Med. 192:549.[Abstract/Free Full Text]
  8. Surh, C. D., J. Sprent. 2000. Homeostatic T cell proliferation: how far can T cells be activated to self-ligands?. J. Exp. Med. 192:F9.[Medline]
  9. Marrack, P., J. Bender, D. Hildman, M. Jordan, T. Mitchell, M. Murakami, A. Sakamoto, B. C. Schaefer, B. Swanson, J. Kappler. 2000. Homeostasis of {alpha}{beta} TCR+ T cells. Nat. Immunol. 1:107.[Medline]
  10. Tanchot, C., F. A. Lemonnier, B. Perarnau, A. A. Freitas, B. Rocha. 1997. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 276:2057.[Abstract/Free Full Text]
  11. Murali-Krishna, K., L. L. Lau, S. Sambhara, F. Lemonnier, J. Altman, R. Ahmed. 1999. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286:1377.[Abstract/Free Full Text]
  12. Lodolce, J. P., D. L. Boone, S. Chai, R. S. Swain, T. Dassopoulos, S. Trettin, A. Ma. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9:669.[Medline]
  13. Kennedy, M. K., M. Glaccum, S. N. Brown, E. A. Butz, J. L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C. R. Willis, et al 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191:771.[Abstract/Free Full Text]
  14. Weninger, W., M. A. Crowley, N. Manjunath, U. H. von Andrian. 2001. Migratory properties of naive, effector, and memory CD8+ T cells. J. Exp. Med. 194:953.[Abstract/Free Full Text]
  15. Tagaya, Y., R. N. Bamford, A. P. DeFilippis, T. A. Waldmann. 1996. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4:329.[Medline]
  16. Waldmann, T. A., Y. Tagaya. 1999. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu. Rev. Immunol. 17:19.[Medline]
  17. Waldmann, T. A., Y. Tagaya, R. N. Bamford. 1998. Interleukin-2, interleukin-15, and their receptors. Int. Rev. Immunol. 16:205.[Medline]
  18. Yoshikai, Y., H. Nishimura. 2000. The role of interleukin 15 in mounting an immune response against microbial infections. Microbes Infect. 4:381.
  19. Carson, W. E., J. G. Giri, M. J. Lindemann, M. L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grabstein, M. A. Caligiuri. 1994. Interleukin (IL)-15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1395.[Abstract/Free Full Text]
  20. Armitage, R. J., B. M. Macduff, J. Eisenman, R. Paxton, K. H. Grabstein. 1995. IL-15 has stipulatory activity for the induction of B cell proliferation and differentiation. J. Immunol. 154:483.[Abstract]
  21. Grabstein, K. H., J. Eisenmann, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M. A. Schoenborn, M. Ahdieh, et al 1994. Cloning of a T-cell growth factor that interacts with the {beta}-chain of the interleukin-2 receptor. Science 246:965.
  22. Nishimura, H., T. Yajima, Y. Naiki, H. Tsunobuchi, M. Umemura, K. Itano, T. Matsuguchi, M. Suzuki, P. S. Ohashi, Y. Yoshikai. 2000. Differential roles of interleukin-15 mRNA isoforms generated by alternative splicing in immune responses in vivo. J. Exp. Med. 191:157.[Abstract/Free Full Text]
  23. Marks-Konczalik, J., S. Dubois, J. M. Losi, H. Sabzevari, N. Yamada, L. Feigenbaum, T. A. Waldmann, Y. Tagaya. 2000. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc. Natl. Acad. Sci. USA 97:11445.[Abstract/Free Full Text]
  24. Yajima, T., H. Nishimura, R. Ishimitsu, K. Yamamura, T. Watase, D. H. Busch, E. G. Pamer, H. Kuwano, Y. Yoshikai. 2001. Memory phenotype CD8+ T cells in IL-15 transgenic mice are involved in early protection against a primary infection with Listeria monocytogenes. Eur. J. Immunol. 31:757.[Medline]
  25. Umemura, M., H. Nishimura, K. Hirose, T. Matsuguchi, Y. Yoshikai. 2001. Overexpression of IL-15 in vivo enhances protection against Mycobacterium bovis bacillus Calmette-Guerin infection via augmentation of NK and T cytotoxic 1 responses. J. Immunol. 167:946.[Abstract/Free Full Text]
  26. Ishimitsu, R., H. Nishimura, T. Yajima, T. Watase, H. Kawauchi, Y. Yoshikai. 2001. Overexpression of IL-15 in vivo enhances Tcl response which inhibits allergic inflammation in a murine model of asthma. J. Immunol. 166:1991.[Abstract/Free Full Text]
  27. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.[Abstract/Free Full Text]
  28. Busch, D. H., I. M. Pilip, S. Vijh, E. G. Pamer. 1998. Coordinate regulation of complex T cell populations responding to bacteria infection. Immunity 8:353.[Medline]
  29. Vijh, S., E. G. Pamer. 1997. Immunodominant and subdominant CTL responses to Listeria monocytogenes infection. J. Immunol. 158:3366.[Abstract]
  30. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, H.-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.[Medline]
  31. Busch, D. H., K. Kerksiek, E. G. Pamer. 1999. Processing of Listeria monocytogenes antigens and the in vivo T-cell response to bacterial infection. Immunol. Rev. 172:163.[Medline]
  32. Grayson, J. M., A. J. Zajac, J. D. Altman, R. Ahmed. 2000. Increased expression of Bcl-2 in antigen-specific memory CD8+ T cells. J. Immunol. 164:3950.[Abstract/Free Full Text]
  33. Sallusto, F., D. Lenig, R. Forster, M. Lipp, A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708.[Medline]
  34. Bonecchi, R., G. Bianchi, P. P. Bordignon, D. D’Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, A. Mantovani, F. Sinigaglia. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:129.[Abstract/Free Full Text]
  35. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofman, V. Steiner, J. L. Bodmer, M. Schroter, K. Burns, C. Mattmann, et al 1997. Inhibition of death receptor signalings by cellular FLIP. Nature 388:190.[Medline]
  36. Miyazaki, T., Z.-J. Liu, A. Kawahara, Y. Minami, K. Yamada, Y. Tsujimoto, E. L. Perlmutter, T. Taniguchi. 1995. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 81:223.[Medline]
  37. Giri, J. G., M. Ahdieh, J. Eisenman, K. Shanebeck, K. Grabstein, S. Kumaki, A. Namen, L. S. Park, D. Cosman, D. Anderson. 1994. Utilization of the {beta}- and {gamma}-chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 8:3667.[Medline]
  38. Tough, D. F., J. Sprent. 1994. Turnover of naive- and memory-phenotype T cells. J. Exp. Med. 179:1127.[Abstract/Free Full Text]
  39. Zhang, X., S. Sun, I. Hwang, D. F. Tough, J. Sprent. 1998. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8:591.[Medline]
  40. Bamford, R. N., A. J. Grant, J. D. Burton, C. Peters, G. Kurys, C. K. Goldman, J. Brennan, E. Roessler, T. A. Waldmann. 1994. The interleukin (IL) 2 receptor {beta}-chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 91:4940.[Abstract/Free Full Text]
  41. Nishimura, H., J. Washizu, N. Nakamura, A. Enomoto, Y. Yoshikai. 1998. Translational efficiency is up-regulated by alternative exon in murine IL-15 mRNA. J. Immunol. 160:936.[Abstract/Free Full Text]
  42. Bamford, R. N., A. P. Battiata, J. D. Burton, H. Sharma, T. A. Waldmann. 1996. Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region/IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation. Proc. Natl. Acad. Sci. USA 93:2897.[Abstract/Free Full Text]
  43. Bamford, R. N., A.P. DeFilippis, N. Azimi, G. Kurys, T. A. Waldmann. 1998. The 5'-untranslated region, signal peptide, and the cording sequence of the carboxyl terminus of IL-15 participate in its multifaceted translational control. J. Immunol. 160:4418.[Abstract/Free Full Text]
  44. Tagaya, Y., G. Kurys, T. A. Thies, J. M. Losi, N. Azimi, J. A. Hanover, R. N. Bamford, T. A. Waldmann. 1997. Generation of secretable and non-secretable interleukin 15 isoforms through alternate usage of signal peptides. Proc. Natl. Acad. Sci. USA 94:14444.[Abstract/Free Full Text]
  45. Onu, A., T. Pohl, H. Krause, S. Bulfone-Paus. 1997. Regulation of IL-15 secretion via the leader peptide of two IL-15 isoform. J. Immunol. 158:255.[Abstract]
  46. Meazza, R., S. Verdiani, R. Biassoni, M. Coppolecchia, A. Gaggero, A. M. Orengo, M. P. Colombo, B. Azzarone, S. Ferrini. 1996. Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines. Oncogene 12:2187.[Medline]
  47. Doherty, T. M., R. A. Seder, A. Sher. 1996. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. :156.
  48. Masopust, D., V. Vezys, A. L. Marzo, L. Lefrancois. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291:2413.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Immunol.Home page
S. C. Morris, S. M. Heidorn, D. R. Herbert, C. Perkins, D. A. Hildeman, M. V. Khodoun, and F. D. Finkelman
Endogenously Produced IL-4 Nonredundantly Stimulates CD8+ T Cell Proliferation
J. Immunol., February 1, 2009; 182(3): 1429 - 1438.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Gill and A. A. Ashkar
Overexpression of Interleukin-15 Compromises CD4-Dependent Adaptive Immune Responses against Herpes Simplex Virus 2
J. Virol., January 15, 2009; 83(2): 918 - 926.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. P. Rubinstein, N. A. Lind, J. F. Purton, P. Filippou, J. A. Best, P. A. McGhee, C. D. Surh, and A. W. Goldrath
IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune response
Blood, November 1, 2008; 112(9): 3704 - 3712.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. I. Kokaji, D. L. Hockley, and K. P. Kane
IL-15 Transpresentation Augments CD8+ T Cell Activation and Is Required for Optimal Recall Responses by Central Memory CD8+ T Cells
J. Immunol., April 1, 2008; 180(7): 4391 - 4401.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Li, H. Yamada, T. Yajima, R. Nakagawa, K. Shimoda, K. Nakayama, and Y. Yoshikai
Tyk2 Signaling in Host Environment Plays an Important Role in Contraction of Antigen-Specific CD8+ T Cells following a Microbial Infection
J. Immunol., April 1, 2007; 178(7): 4482 - 4488.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Nakazato, H. Yamada, T. Yajima, Y. Kagimoto, H. Kuwano, and Y. Yoshikai
Enforced Expression of Bcl-2 Partially Restores Cell Numbers but Not Functions of TCR{gamma}{delta} Intestinal Intraepithelial T Lymphocytes in IL-15-Deficient Mice
J. Immunol., January 15, 2007; 178(2): 757 - 764.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. J. Lucas, S.-J. Kim, C. L. Mackall, W. G. Telford, Y.-W. Chu, F. T. Hakim, and R. E. Gress
Dysregulation of IL-15-mediated T-cell homeostasis in TGF-beta dominant-negative receptor transgenic mice
Blood, October 15, 2006; 108(8): 2789 - 2795.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Saito, T. Yajima, S. Kumabe, T. Doi, H. Yamada, S. Sad, H. Shen, and Y. Yoshikai
Impaired Protection against Mycobacterium bovis Bacillus Calmette-Guerin Infection in IL-15-Deficient Mice
J. Immunol., February 15, 2006; 176(4): 2496 - 2504.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Yajima, K. Yoshihara, K. Nakazato, S. Kumabe, S. Koyasu, S. Sad, H. Shen, H. Kuwano, and Y. Yoshikai
IL-15 Regulates CD8+ T Cell Contraction during Primary Infection
J. Immunol., January 1, 2006; 176(1): 507 - 515.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Nishimura, T. Yajima, H. Muta, E. R. Podack, K. Tani, and Y. Yoshikai
A Novel Role of CD30/CD30 Ligand Signaling in the Generation of Long-Lived Memory CD8+ T Cells
J. Immunol., October 1, 2005; 175(7): 4627 - 4634.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. N. Toka and B. T. Rouse
Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity
J. Leukoc. Biol., July 1, 2005; 78(1): 178 - 186.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
V. Lazarevic, D. J. Yankura, S. J. Divito, and J. L. Flynn
Induction of Mycobacterium tuberculosis-Specific Primary and Secondary T-Cell Responses in Interleukin-15-Deficient Mice
Infect. Immun., May 1, 2005; 73(5): 2910 - 2922.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Yajima, H. Nishimura, S. Sad, H. Shen, H. Kuwano, and Y. Yoshikai
A Novel Role of IL-15 in Early Activation of Memory CD8+ CTL after Reinfection
J. Immunol., March 15, 2005; 174(6): 3590 - 3597.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. W. Blaser, S. Roychowdhury, D. J. Kim, N. R. Schwind, D. Bhatt, W. Yuan, D. F. Kusewitt, A. K. Ferketich, M. A. Caligiuri, and M. Guimond
Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease
Blood, January 15, 2005; 105(2): 894 - 901.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
B. Gilbertson, S. Germano, P. Steele, S. Turner, B. F. de St. Groth, and C. Cheers
Bystander Activation of CD8+ T Lymphocytes during Experimental Mycobacterial Infection
Infect. Immun., December 1, 2004; 72(12): 6884 - 6891.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. Yajima, H. Nishimura, K. Saito, H. Kuwano, and Y. Yoshikai
Overexpression of Interleukin-15 Increases Susceptibility to Lipopolysaccharide-Induced Liver Injury in Mice Primed with Mycobacterium bovis Bacillus Calmette-Guerin
Infect. Immun., July 1, 2004; 72(7): 3855 - 3862.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. M. Johnson
Murine Oviduct Epithelial Cell Cytokine Responses to Chlamydia muridarum Infection Include Interleukin-12-p70 Secretion
Infect. Immun., July 1, 2004; 72(7): 3951 - 3960.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. C. Lenz, S. K. Kurz, E. Lemmens, S. P. Schoenberger, J. Sprent, M. B. A. Oldstone, and D. Homann
IL-7 regulates basal homeostatic proliferation of antiviral CD4+T cell memory
PNAS, June 22, 2004; 101(25): 9357 - 9362.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
B. P. Lawrence and B. A. Vorderstrasse
Activation of the Aryl Hydrocarbon Receptor Diminishes the Memory Response to Homotypic Influenza Virus Infection but Does Not Impair Host Resistance
Toxicol. Sci., June 1, 2004; 79(2): 304 - 314.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. M. Huster, V. Busch, M. Schiemann, K. Linkemann, K. M. Kerksiek, H. Wagner, and D. H. Busch
Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets
PNAS, April 13, 2004; 101(15): 5610 - 5615.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
M. Giri, K. E. Ugen, and D. B. Weiner
DNA Vaccines against Human Immunodeficiency Virus Type 1 in the Past Decade
Clin. Microbiol. Rev., April 1, 2004; 17(2): 370 - 389.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Rothenfusser, V. Hornung, M. Ayyoub, S. Britsch, A. Towarowski, A. Krug, A. Sarris, N. Lubenow, D. Speiser, S. Endres, et al.
CpG-A and CpG-B oligonucleotides differentially enhance human peptide-specific primary and memory CD8+ T-cell responses in vitro
Blood, March 15, 2004; 103(6): 2162 - 2169.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Chapdelaine, D. K. Smith, J. A. Pedras-Vasconcelos, L. Krishnan, and S. Sad
Increased CD8+ T Cell Memory to Concurrent Infection at the Expense of Increased Erosion of Pre-existing Memory: The Paradoxical Role of IL-15
J. Immunol., November 15, 2003; 171(10): 5454 - 5460.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Umemura, H. Nishimura, K. Saito, T. Yajima, G. Matsuzaki, S. Mizuno, I. Sugawara, and Y. Yoshikai
Interleukin-15 as an Immune Adjuvant To Increase the Efficacy of Mycobacterium bovis Bacillus Calmette-Guerin Vaccination
Infect. Immun., October 1, 2003; 71(10): 6045 - 6048.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Tritel, A. M. Stoddard, B. J. Flynn, P. A. Darrah, C.-y. Wu, U. Wille, J. A. Shah, Y. Huang, L. Xu, M. R. Betts, et al.
Prime-Boost Vaccination with HIV-1 Gag Protein and Cytosine Phosphate Guanosine Oligodeoxynucleotide, Followed by Adenovirus, Induces Sustained and Robust Humoral and Cellular Immune Responses
J. Immunol., September 1, 2003; 171(5): 2538 - 2547.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Berard, K. Brandt, S. B. Paus, and D. F. Tough
IL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells
J. Immunol., May 15, 2003; 170(10): 5018 - 5026.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Oh, J. A. Berzofsky, D. S. Burke, T. A. Waldmann, and L. P. Perera
Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity
PNAS, March 18, 2003; 100(6): 3392 - 3397.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. M. Mueller, P. M. Bojczuk, E. S. Halstead, A. H. J. Kim, J. Witek, J. D. Altman, and P. D. Katsikis
IL-15 enhances survival and function of HIV-specific CD8+ T cells
Blood, February 1, 2003; 101(3): 1024 - 1029.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M.-C. Meunier, G. Roy-Proulx, N. Labrecque, and C. Perreault
Tissue distribution of target antigen has a decisive influence on the outcome of adoptive cancer immunotherapy
Blood, January 15, 2003; 101(2): 766 - 770.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
Y. M. Mueller, V. Makar, P. M. Bojczuk, J. Witek, and P. D. Katsikis
IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells
Int. Immunol., January 1, 2003; 15(1): 49 - 58.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. P. Rubinstein, A. N. Kadima, M. L. Salem, C. L. Nguyen, W. E. Gillanders, and D. J. Cole
Systemic Administration of IL-15 Augments the Antigen-Specific Primary CD8+ T Cell Response Following Vaccination with Peptide-Pulsed Dendritic Cells
J. Immunol., November 1, 2002; 169(9): 4928 - 4935.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. Prlic, L. Lefrancois, and S. C. Jameson
Multiple Choices: Regulation of Memory CD8 T Cell Generation and Homeostasis by Interleukin (IL)-7 and IL-15
J. Exp. Med., June 17, 2002; 195(12): F49 - F52.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yajima, T.
Right arrow Articles by Yoshikai, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yajima, T.
Right arrow Articles by Yoshikai, Y.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS